ZOLL Unveils Remote View on X Series Monitor/Defibrillator
July 9, 2020—CHELMSFORD, MA —ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today that it has launched its new remote view technology on the X Series® monitor/defibrillator developed for EMS agencies.
Remote view capability on the X Series allows a clinician to view the X Series screen remotely while a patient is being monitored. The new technology permits a clinician to see two waveforms and the patient’s vitals, including the patient’s temperature, heart rate, SpO2, and end-tidal CO2. The remote clinician is also able to view 12-lead snapshots and trend reports.
“ZOLL is proud to offer remote view capabilities, which are a critical component of patient care in today’s environment,” said ZOLL CEO Jonathan A. Rennert. “This new technology can help minimize clinician exposure to COVID-19 and prevent patients from entering a hospital setting unnecessarily, where they could be exposed to the virus.”
“Remote view is also a critical tool for EMS agencies following the ET3 model, where advice from a specialist is required to determine where to transport, as well as for community paramedicine/mobile integrated healthcare (MIH) programs,” Mr. Rennert added. “In emergency situations, it is paramount that first responders and clinicians share real-time critical care data to help improve patient outcomes.”
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, supersaturated oxygen therapy, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 40,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit www.asahi-kasei.com.
